Lv61
2070 积分 2023-07-18 加入
Systemic lupus erythematosus
7天前
已完结
A bispecific CD3×CD19 antibody for systemic lupus erythematosus: a phase 1 trial
20天前
已完结
Structure basis for C-C chemokine receptor 4 modulation by orthosteric and allosteric antagonists
1个月前
已完结
Efficacy of the Bispecific Anti‐BAFF/IL‐21 Antibody CZ105 Bis2 in Models of Systemic Lupus Erythematosus
1个月前
已完结
Pan-organ damage analysis in the R848-induced systemic lupus erythematosus mouse model
1个月前
已完结
Systemic lupus erythematosus: Phase 2 trials to watch in 2026
2个月前
已关闭
Positive results for obinutuzumab in SLE phase III trial
2个月前
已完结
A Phase 3 Trial of Telitacicept for Systemic Lupus Erythematosus
2个月前
已完结
Efficacy and safety of the CD40 ligand inhibitor dapirolizumab pegol in systemic lupus erythematosus (PHOENYCS GO): a randomised, double-blind, placebo-controlled, phase 3 trial
2个月前
已完结
2025 American College of Rheumatology ( ACR ) Guideline for the Treatment of Systemic Lupus Erythematosus
2个月前
已完结
皖公网安备34019202002308
